http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085655-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5255 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-28 |
| filingDate | 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105085655-B |
| titleOfInvention | With the human protein LT- α of HGV RNA E2 protein-interacting |
| abstract | The invention discloses a kind of human protein LT- α with HGV RNA interaction, amino acid sequence is as shown in SEQ ID NO:1, shown in the nucleotide sequence SEQ ID NO:2 of the gene of coding human protein LT- α；It is screened by HGV RNA E2 albumen to human T-lymphocyte cDNA library using the method for forth generation yeast two-hybrid, the human protein with HGV RNA E2 protein-interacting is obtained, and positive verification is carried out to interaction albumen by the method for co-immunoprecipitation；The present invention can provide certain theoretical basis for the mechanism of action between research HGV RNA and HIV-1 virus. |
| priorityDate | 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 293.